Literature DB >> 19261472

Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.

Yi-Long Yan1, Melissa T Miller, Yuchen Cao, Seth M Cohen.   

Abstract

The zinc(II)-dependent matrix metalloproteinases (MMPs) are associated with a variety of diseases. Development of inhibitors to modulate MMP activity has been an active area of investigation for therapeutic development. Hydroxypyrones and hydroxythiopyrones are alternative zinc-binding groups (ZBGs) that, when combined with peptidomimetic backbones, comprise a novel class of MMP inhibitors (MMPi). In this report, a series of hydroxypyrone- and hydroxythiopyrone-based MMPi with aryl backbones at the 2-, 5-, and 6-positions of the hydroxypyrone ring have been synthesized. Synthetic routes for developing inhibitors with substituents at two of these positions (so-called double-handed inhibitors) are also explored. The MMP inhibition profiles and structure-activity relationship of synthesized hydroxypyrones and hydroxythiopyrones have been analyzed. The results here show that the ZBG, the position of the backbone on the ZBG, and the nature of the linker between the ZBG and backbone are critical for MMPi activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19261472      PMCID: PMC2833267          DOI: 10.1016/j.bmcl.2009.02.044

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  25 in total

1.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Rational design of sequestering agents for plutonium and other actinides.

Authors:  Anne E V Gorden; Jide Xu; Kenneth N Raymond; Patricia Durbin
Journal:  Chem Rev       Date:  2003-11       Impact factor: 60.622

3.  Evaluation and binding-mode prediction of thiopyrone-based inhibitors of anthrax lethal factor.

Authors:  Jana A Lewis; John Mongan; J Andrew McCammon; Seth M Cohen
Journal:  ChemMedChem       Date:  2006-07       Impact factor: 3.466

Review 4.  From miso, saké and shoyu to cosmetics: a century of science for kojic acid.

Authors:  Ronald Bentley
Journal:  Nat Prod Rep       Date:  2006-10-18       Impact factor: 13.423

5.  Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.

Authors:  Katayoun Saatchi; Katherine H Thompson; Brian O Patrick; Maren Pink; Violet G Yuen; John H McNeill; Chris Orvig
Journal:  Inorg Chem       Date:  2005-04-18       Impact factor: 5.165

6.  Potent, selective pyrone-based inhibitors of stromelysin-1.

Authors:  David T Puerta; John Mongan; Ba L Tran; J Andrew McCammon; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2005-10-19       Impact factor: 15.419

7.  Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.

Authors:  Z D Liu; S Piyamongkol; D Y Liu; H H Khodr; S L Lu; R C Hider
Journal:  Bioorg Med Chem       Date:  2001-03       Impact factor: 3.641

8.  New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.

Authors:  David T Puerta; Jana A Lewis; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2004-07-14       Impact factor: 15.419

9.  Efficient synthesis of 5-amido-3-hydroxy-4-pyrones as inhibitors of matrix metalloproteinases.

Authors:  Yi-Long Yan; Seth M Cohen
Journal:  Org Lett       Date:  2007-05-24       Impact factor: 6.005

Review 10.  The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.

Authors:  Jerry W Skiles; Nina C Gonnella; Arco Y Jeng
Journal:  Curr Med Chem       Date:  2004-11       Impact factor: 4.530

View more
  5 in total

1.  Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Authors:  Jennifer A Jacobsen; Jessica L Fullagar; Melissa T Miller; Seth M Cohen
Journal:  J Med Chem       Date:  2010-12-28       Impact factor: 7.446

2.  Metalloprotein-inhibitor binding: human carbonic anhydrase II as a model for probing metal-ligand interactions in a metalloprotein active site.

Authors:  David P Martin; Zachary S Hann; Seth M Cohen
Journal:  Inorg Chem       Date:  2013-05-24       Impact factor: 5.165

3.  Targeting metalloproteins by fragment-based lead discovery.

Authors:  Sherida Johnson; Elisa Barile; Biancamaria Farina; Angela Purves; Jun Wei; Li-Hsing Chen; Sergey Shiryaev; Ziming Zhang; Irina Rodionova; Arpita Agrawal; Seth M Cohen; Andrei Osterman; Alex Strongin; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2011-06-16       Impact factor: 2.817

4.  Insights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculations.

Authors:  Ilenia Giangreco; Gianluca Lattanzi; Orazio Nicolotti; Marco Catto; Antonio Laghezza; Francesco Leonetti; Angela Stefanachi; Angelo Carotti
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

Review 5.  Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma.

Authors:  Salvatore Napoli; Chiara Scuderi; Giuseppe Gattuso; Virginia Di Bella; Saverio Candido; Maria Sofia Basile; Massimo Libra; Luca Falzone
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.